University of California San Francisco
Give to UCSF
In a first, scientists at UCSF and Stanford identified genetic variants that predict whether a patient is likely to respond to treatment for preterm birth. Screening for mutations could allow doctors to target medications to those most likely to benefit. No medication is currently available in the U.S. to treat preterm birth.
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug.
Young Black and Hispanic women with multiple sclerosis fare worse than young white women with the disease. Minority women were more likely to have more advanced disease and faced greater challenges in pregnancy.
Andrea V. Jackson, MD, MAS, a highly regarded obstetrician, gynecologist and diversity champion, has been appointed chair of the UCSF Department of Obstetrics, Gynecology & Reproductive Sciences.
Early identification of posterior cortical atrophy (PCA) may have important implications for Alzheimer’s treatment. PCA patients struggle with visual impairments like judging distances, distinguishing between moving and stationary objects and completing tasks like writing and retrieving a dropped item.
A little-studied steroid that serves as a building block for hormones like estrogen and testosterone has been shown to enhance learning and memory in a new study by researchers at UC San Francisco.
Fruit bats have a genetic system that controls blood sugar without fail. Learning from that system can help us make better insulin- or sugar-sensing therapies for human patients.
The Danaher-IGI Beacon for CRISPR Cures center will use genome editing to address potentially hundreds of diseases, including rare genetic disorders that have no cure, to ensure treatments can be developed and brought to patients more quickly and efficiently.
A newly-discovered gene may explain how humans go deaf both as they age, and in response to loud noise.
A study of seriously ill patients from academic medical centers across the country has found that nearly a quarter had a delayed or missed diagnosis.
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals
UCSF does not have an official mascot, but you’re bound to run into at least a few that agree the University’s “unofficial” mascot is a bear.
Quality of sleep, not quantity, may play a part in the development of dementia decades before symptoms start.
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T
A team of researchers from UC San Francisco has found that Paxlovid did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.
C. Benjamin Ma, MD, a highly regarded orthopaedic surgeon and advanced imaging researcher, has been appointed as chair of the UCSF Department of Orthopaedic Surgery. Ma will assume his new role on Jan
The new JN.1 COVID-19 variant is now estimated to make up about 20% of cases in the United States. Three UCSF experts offer advice on vaccines, masking, and other ways to protect yourself.
This award-winning podcast series draws on the personal stories of more than 200 health care workers to explore how shame manifests in medicine. UCSF hospitalist and resident alum Emily Silverman, MD – who calls shame “the elephant in the room” – hosts the series, which is a collaboration between her Nocturnists podcast and the University of Exeter’s Shame in Medicine project.
“You are here because you are a genius in every right,” says Sydney Williams in this video about the graduate student organization BE-STEM (Black Excellence in Science, Technology, Engineering, and Math) and the exceptional leadership of Williams, Jaysón Davidson, and Christina Stephens. Find it on UCSF’s YouTube channel.
The Washington Post calls this novel “a time-spanning, genre-blurring work of storytelling magic.” Written by Daniel Mason, MD ’04, it’s the tale of a house in the New England woods, told through the lives of its inhabitants across the centuries.